Related references
Note: Only part of the references are listed.Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003
Arkadiusz Z. Dudek et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer A Nonrandomized Controlled Trial
Salma K. Jabbour et al.
JAMA ONCOLOGY (2020)
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Steven F. Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients
Nicola Alessandro Iacovelli et al.
FRONTIERS IN ONCOLOGY (2020)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Management of locally recurrent nasopharyngeal carcinoma
Anne W. M. Leea et al.
CANCER TREATMENT REVIEWS (2019)
Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis
Yiat Horng Leong et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival
C. Dubot et al.
EUROPEAN JOURNAL OF CANCER (2018)
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma
Wai-Tong Ng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B. Y. Ma et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
Yun-Hsuan Lin et al.
RADIATION ONCOLOGY (2018)
Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
Fangfang Kong et al.
BMC CANCER (2018)
Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma
Victor H. F. Lee et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma
Oscar S. H. Chan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Chiun Hsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma
Ying Guan et al.
CHINESE JOURNAL OF CANCER (2016)
Radio-immunotherapy: the focused beam expands
Benjamin Frey et al.
LANCET ONCOLOGY (2015)
Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - A case-matched comparison
Rui You et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma
Xiong Zou et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Copy number alteration burden predicts prostate cancer relapse
Haley Hieronymus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
Fei Han et al.
CLINICAL ONCOLOGY (2012)
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy
Yi-Jun Hua et al.
EUROPEAN JOURNAL OF CANCER (2012)
Intensity-Modulated Radiation Therapy in the Salvage of Locally Recurrent Nasopharyngeal Carcinoma
Sufang Qiu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation
Anurag Gupta et al.
JOURNAL OF IMMUNOLOGY (2012)
The prevalence and prevention of nasopharyngeal carcinoma in China
Su-Mei Cao et al.
Chinese Journal of Cancer (2011)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma
XK Zheng et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins
B Bucci et al.
CLINICAL CANCER RESEARCH (2005)
Reirradiation for locally recurrent nasopharyngeal carcinoma:: Treatment results and prognostic factors
DÇ Öksüz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line
WJ Kim et al.
ONCOGENE (2002)
Share Paper
